A landmark study from MHRA and University of Liverpool reveals the UK’s leadership in drug development and outlines …
A landmark study from MHRA and University of Liverpool reveals the UK’s leadership in drug development and outlines …
Fresh guidelines and a reshaped regulatory framework pave the way for smoother clinical research, even as COVID-19 maintains …
Prime Minister Starmer unveils ambitious reforms to speed up trial timelines and centralize NHS data, aiming to restore …
An investigational RNA-based therapy shows significant reduction in disease-causing protein levels—potentially a meaningful step forward in treating Huntington’s …
Megafunding rounds and regulatory momentum reshaped the biotech investment landscape, signaling growing confidence in transformative clinical innovation.
Topical laquinimod reaches posterior eye tissues with dose-related distribution and good tolerability in patients preparing for vitrectomy
The biotech sector saw compelling developments from funding milestones to shifts in trial regulations and rising promise in …
Early-stage data reveal tumour targeting and tolerability with radiolabelled GRPR antagonist therapy in metastatic prostate cancer
New AI-powered system promises to reduce inefficiencies in trial recruitment by automating eligibility prediction
Vera Therapeutics completed full enrolment in its pivotal trial of atacicept in IgA nephropathy and Minovia Therapeutics received …